Twist Bioscience Corp
StreetZero Signal 62
About Twist Bioscience Corp
Twist Bioscience Corporation is a biotechnology company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform. It is a public company listed on NASDAQ under TWST and operates in the biotechnology research industry with a B2B business model. The company is headquartered in South San Francisco, California, and was founded in 2013.
LATEST FUNDINGRule 144
$1.8M
Announced 2026-11-19
IN THE NEWS
- ๐ Twist Completes $107.4 Million Follow-On Offering | Baird
- ๐ Twist Bioscience
- ๐ Twist Bioscience | Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwritersโ Option to Purchase Additional Shares
- ๐ S-1
- ๐ Twist Bioscience Stock Price Today NASDAQ TWST - Investing.com Canada
EMPLOYEESโ
FOUNDED2013
HQSouth San Francisco, CA, United States
Industry
Public Equity (NASDAQ)
Tags
B2BBiotechnologySynthetic DNAPublic
Investors
Not disclosed in the source filing. Form D filings do not list investors โ StreetZero surfaces them from news where available.
Key highlights
- Completed $107.4M follow-on public offering of common stock in June 2020.
- Public company on NASDAQ:TWST with multiple post-IPO equity raises including $250M rounds.
- Develops high-quality synthetic DNA on a silicon platform for NGS, synbio, and biologics.
- Headquartered in South San Francisco with 189k+ LinkedIn followers.
- Uses offering proceeds for R&D, capacity expansion, and working capital.
Ask StreetZero about Twist Bioscience Corp
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account